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Brief Technique ReportsEvaluation of a new left atrial retractor for minimally invasive mitral
valve surgeryOlivier Jegaden, MD, Thomas Sassard, MD, Abdel Shafy, MD, Mouhcine Madani, MD, and
Fadi Farhat, MD, PhD, Bron, FranceExposure of the mitral valve is a key success factor in min-
imally invasivemitral valve surgery (MIMVS) and a prereq-
uisite for successful mitral valve repair.1 We report the
concept of a new left atrial retractor (MitraXs, St Jude Med-
ical Inc, Minneapolis, Minn) dedicated to MIMVS. The ef-
fectiveness of the device was evaluated in a prospective
series.FIGURE 1. The MitraXs (St Jude Medical Inc, Minneapolis, Minn) is
a self-supporting atrial retractor. A, In deployed position with 1 overmod-
uled pivoting rivet that makes its conical shape self-expanding and auto-ad-
justing. B, In rolled and compressed position, with triangular tab protruding
out of the cylinder, which makes introduction into the left atrium easy.CLINICAL SUMMARY
The MitraXs retractor is a pattern-cut polymer sheet that
once deployed and secured by a pivoting rivet generates
a conical volume (Figure 1). The device is a self-expanding,
auto-adjusting, single-use left atrial retractor that does not
require a supporting arm. The retractor has 2 sizes (A and
B) according to valve diameter and 2 lengths (regular or ‘‘
þ’’) according to atrium depth to accommodate anatomic
variations.
The introduction and deployment of the MitraXs device
are key points. After the folding step, the MitraXs device
is rolled and compressed from a conical shape to a cylinder
with a reduced diameter creating a protruding triangular tab
(Figure 1). By using a locking forceps, theMitraXs device is
introduced via a minithoracotomy and an atriotomy, the tab
with the rivet at the top loading the atrial septum first; then,
with a clockwise rotation of a half turn, the device is pro-
gressively pushed into the left atrium in a screwing move-
ment. When the MitraXs device is completely engaged in
the left atrium, centered on the valve, with the rivet down
in the posterior position, the forceps is released and the re-
tractor deploys back into an optimal conical shape, working
as an ‘‘expander’’ and maintaining the left atriumwide open
in a symmetric manner.
The effectiveness of the MitraXs device was evaluated in
62 patients who consecutively underwent MIMVS during
a 20-month period at the Louis Pradel Hospital. ThereFrom the Louis Pradel Hospital, Cardiac Surgery and Transplantation, Bron, France.
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The Journal of Thoracic and Cawere 21 female and 41 male patients with a mean age of
61 17 years and a euroSCORE of 5.6 2.8. The operation
was a redo in 6 cases, with previous mitral valve surgery in 4
patients and previous coronary artery bypass grafting in 2
patients. The origin of mitral valve lesions was rheumatic
in 11 patients, degenerative in 45 patients, endocarditis in
2 patients, and bioprosthesis dysfunction in 4 patients.
The surgical procedure was based on the principles of
MIMVS with a transthoracic aortic clamp.2 The MitraXs
device was used in all cases as the primary indication for
mitral valve exposure. The following were analyzed for
each procedure: introduction of the retractor, sizerdiovascular Surgery c Volume 141, Number 1 297
FIGURE 2. Intraoperative view. A, The mitral valve is nicely exposed
without distortion, allowing easy and accurate analysis of the lesion. The
left atrial muscle is homogeneously unfolded, providing space for suturing.
B, The mitral valve is visualized in its entirety with a large working space,
making en bloc valve resection possible. Note the asanguineous operative
field with the vent back. The MitraXs device may prevent tissue fragments
from falling into the pulmonary veins.
FIGURE 3. Intraoperative view. A, TheMitraXs device is voluntarily cen-
tered on the posterior leaflet tomake sliding plasty easier. Note the occluded
area on anterior annulus that is accessible by sliding and repositioning. B,
The MitraXs device is voluntarily pushed inside the mitral annulus to
improve the exposure of papillary muscles for artificial chordae implanta-
tion.
Brief Technique Reportssuitability, conversion to blade retractor, exposure of the mi-
tral valve, distortion of the anatomy, working space avail-
able around the valve, access for endoscopic instruments,
need of repositioning or additional stitches to improve ex-
posure, video and direct vision, and extraction of the device.
At the end of the procedure, the surgeon proposed a global
satisfaction index from 0 to 5.
RESULTS
Mitral valve replacement was performed in 18 patients,
and mitral valve repair was performed in 44 patients. An as-
sociated procedure was performed in 8 patients: myomec-
tomy in 2 patients, atrial septal defect closure in 4
patients, and tricuspid valve repair in 2 patients. For mitral298 The Journal of Thoracic and Cardiovascular Surgvalve repair, a posterior leaflet resection was performed in
28 patients and artificial chordae were used in 19 patients,
mainly on the anterior leaflet; an annuloplasty using a com-
plete semirigid ring was associated in all cases.
The introduction of the MitraXs device was fast and easy,
with a mean placement time of 32  8 seconds. There was
a mismatch in 5 cases, and a smaller-sized MitraXs device
was used. Size A was used in 34 patients (A, 21; Aþ, 13),
and size B was used in 28 patients (B, 22; Bþ, 6). The Mi-
traXs device was used in all procedures without an addi-
tional retractor or conversion to a different retractor. The
exposure of themitral valve, in regard to both leaflets and an-
nulus, was estimated to be good to perfect in 47 cases, with
the left atrial muscle homogeneously unfolded around the
valve (Figure 2). In 15 cases of mitral valve repair, theery c January 2011
Brief Technique Reportsanterior part of the annulus was partially hidden; in 9 cases,
the repair of the well-exposed mitral valve was performed
first and repositioning was done for ring implantation in
the occluded area (Figure 3, A), and in 6 cases, sutures for
ring implantation were placed first using sequential reposi-
tioning to downsize the valve diameter enough to be in-
cluded in the internal diameter of the MitraXs device.
Repositioning was easily performed with hooks in a sliding
movement. In all cases, there was no distortion of the valve
anatomy, which made the analysis of valve dysfunction easy
and reliable in repair procedures. In 8 patients, to improve
accessibility to the papillary muscles for artificial chordae
implantation, the MitraXs device was first pushed inside
the annulus to throw back the posterior leaflet (Figure 3,
B). The same techniquewas used in 2 patients for associated
myomectomy. In 4 patients, theMitraXs device (sizeþ) slip-
ped out of the left atrium during the procedure because of ex-
cessive traction on the annulus stitches, which progressively
ejected the device; in 2 patients the device was successfully
reintroduced into the left atrium, and in 2 patients the device
was removed and ring implantation was finished without
a retractor. An ideal straight line between the working port
of the minithoracotomy and the plane of the mitral valve
was obtained in most cases via a lateral thoracic approach;
however, in 8 patients a ‘‘bayonet’’ effect was corrected us-
ing a traction stitch. In all patients, excellent direct vision
was provided by the device. The vent placed in the pulmo-
nary veins remained back without displacement or conflict.
Repeat cardioplegiawas performed with theMitraXs device
in place, demonstrating no distortion of the aortic valve. In
case of an associated right atrium approach for atrial septal
defect or tricuspid surgery, the MitraXs device was used on
the right side without the rivet engaged, working as a tent.
Removal of the devicewas performed in a compressed cylin-
dric shape (n¼ 51) or a flat shape after the rivet release (n¼
11). The global satisfaction indexwas 4.6 0.5. All patients
had a good outcome and were discharged from the hospital.
DISCUSSION
Optimal exposure of the mitral valve is a key point in
MIMVS. Since our program was started in 1997, we haveThe Journal of Thoracic and Caused the classic 2-piece blade retractor dedicated to such
a procedure and observed its drawbacks related to the trac-
tion on the anterior leaflet with distortion of the mitral ap-
paratus, the creation of atrial folds with large occluded
areas, and the difficulty of not exposing the anterior annulus
for ring implantation.3 The concept of the MitraXs device is
based not on left atrial retraction but on left atrial expan-
sion; thus, these drawbacks are not relevant. The associa-
tion of a small left atrium with a dilated annulus was
a difficult situation; the atrium diameter took the lead,
and we had to accept a covered area in 24% of cases, no
more than 10% on the anterior annulus. This drawback
was offset by the freedom of the MitraXs device inside
the left atrium, and repositioning was easy to modify the ex-
posure according to the surgical stage. In the same manner,
it was possible to focus the exposure on a specific area, such
as the posterior annulus for sliding plasty or the papillary
muscle for artificial chordae (Figure 3). In most cases, the
MitraXs device provided optimal exposure and excellent
direct vision. The global satisfaction index was high, dem-
onstrating the effectiveness of the device; however, the Mi-
traXs device has a few drawbacks. Size standardization
may involve mismatch. Downsized or in case of excessive
traction on annulus stitches, the MitraXs device may slip
out of the left atrium.CONCLUSIONS
The MitraXs is easy to use with excellent effective-
ness. Since testing the device, we have adopted its use.
According to our experience and the results of this series,
the MitraXs makes the technique of MIMVS easier and
more reproducible.References
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